Coniferyl ferulate

Synonyms: 阿魏酸松柏酯
Coniferyl ferulate 是一种口服有效的酚酸类化合物,作为谷胱甘肽 S-转移酶 (GST) 的强效抑制剂 (IC50 = 0.3 μM),它可下调 P-gp 表达、诱导 B-MD-C1 (ADR+/+) 细胞凋亡 (apoptosis) 并逆转多药耐药性,同时通过阻断 NMDAR/NR2B-CaMKII-MAPKs 信号通路、抑制 ROS 产生和线粒体凋亡、重塑肠道微生物群和微生物代谢来改善小鼠结肠炎症并减轻其抑郁症状,还能通过靶向 Mgst2 减轻二甲苯对造血干细胞和祖细胞的毒性,并对革兰氏阳性菌枯草芽孢杆菌和金黄色葡萄球菌具有抗菌活性。
产品编号: MS-G65654 纯度: 98.73% CAS No.: 63644-62-2 分子式: C20H20O6 分子量: 356.37
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价

产品描述

Coniferyl ferulate 是一种口服有效的酚酸类化合物,作为谷胱甘肽 S-转移酶 (GST) 的强效抑制剂 (IC50 = 0.3 μM),它可下调 P-gp 表达、诱导 B-MD-C1 (ADR+/+) 细胞凋亡 (apoptosis) 并逆转多药耐药性,同时通过阻断 NMDAR/NR2B-CaMKII-MAPKs 信号通路、抑制 ROS 产生和线粒体凋亡、重塑肠道微生物群和微生物代谢来改善小鼠结肠炎症并减轻其抑郁症状,还能通过靶向 Mgst2 减轻二甲苯对造血干细胞和祖细胞的毒性,并对革兰氏阳性菌枯草芽孢杆菌和金黄色葡萄球菌具有抗菌活性。

生物实验数据

生物活性 Coniferyl ferulate is an orally effective phenolic acid compound that acts as a potent inhibitor of glutathione S-transferase (GST) (IC50 = 0.3 μM), downregulates P-gp expression, induces apoptosis in B-MD-C1 (ADR+/+) cells, and reverses multidrug resistance, while also ameliorating colonic inflammation and alleviating depressive symptoms in mice by blocking the NMDAR/NR2B-CaMKII-MAPKs signaling pathway, inhibiting ROS production and mitochondrial apoptosis, and remodeling the gut microbiota and microbial metabolism, and it can mitigate xylene-induced toxicity to hematopoietic stem and progenitor cells by targeting Mgst2, and exhibits antibacterial activity against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus.
IC50 & Target

CaMK II

 

NMDA Receptor

 

体外研究
(In Vitro)

Coniferyl ferulate (5-20 μM, 48 h) 在 B-MD-C1 (ADR+/+) 细胞中诱导凋亡,并阻滞细胞周期于 G1 期。
Coniferyl ferulate (5-20 μM, 48 h) 抑制 Doxorubicin (HY-15142A) 引起的 MDR1/P-gp 上调,并使 B-MD-C1 (ADR+/+) 细胞中 P-gp 的表达接近正常水平。
Coniferyl ferulate (0.2-20 μM, 28 h) 过阻断 NMDA-CaMKII-MAPKs 信号级联、降低 ROS 水平和增强 SOD 活性,保护 PC12 细胞免受 Glutamate (MS-G05955) 诱导的细胞活力下降和凋亡,减轻细胞膜损伤。

Apoptosis Analysis

Cell Line: B-MD-C1(ADR+/+) cells
Concentration: 5, 10 and 20 μM
Incubation Time: 48 h
Result: Induced apoptosis.

Cell Cycle Analysis

Cell Line: B-MD-C1(ADR+/+) cells
Concentration: 5, 10 and 20 μM
Incubation Time: 48 h
Result: Markedly increased the proportion of cells in G1-phase, decreased the proportion of cells in S-phase.

RT-PCR

Cell Line: B-MD-C1(ADR+/+) cells
Concentration: 5, 10 and 20 μM
Incubation Time: 48 h
Result: Dose-dependently inhibited Doxorubicin-induced MDR1 overexpression.
Brought the expression of P-gp close to the basal level.

Cell Viability Assay

Cell Line: Glutamate-damaged PC12 cells
Concentration: 0.2, 2, 20 μM
Incubation Time: After 4 hours of pre-treatment, with Glutamate for another 24 hours
Result: Concentration-dependently protected the decline in cell viability induced by Glutamate.
Significantly alleviated the damage to the cell membrane caused by Glutamate.

Apoptosis Analysis

Cell Line: Glutamate-damaged PC12 cells
Concentration: 0.2, 2, 20 μM
Incubation Time: After 4 hours of pre-treatment, with Glutamate for another 24 hours
Result: Reduced nuclear shrinkage and PI-positive cells.

Apoptosis Analysis

Cell Line: Glutamate-damaged PC12 cells
Concentration: 0.2, 2, 20 μM
Incubation Time: After 4 hours of pre-treatment, with Glutamate for another 24 hours
Result: Decreased the level of p-NR2B, p-CaMKII, p-JNK and p-p38.
Increased the Bcl-2/Bax ratio and decreased the release of cytochrome C and activation of Caspase-3.
体内研究
(In Vivo)

Coniferyl ferulate (25-100 mg/kg, i.g., 每天一次共 13-14 天) 在小鼠行为测试中具有抗抑郁作用。
Coniferyl ferulate (50 mg/kg, i.g., 每天一次共 4 周) 可减轻慢性不可预测温和应激 (CUMS) 诱导的类抑郁和类焦虑行为,并显著改善小鼠结肠炎症。
Coniferyl ferulate (50 mg/kg, i.g., 每天一次共 25 天) 通过抑制 Mgst2 减轻二甲苯引起的小鼠造血干细胞和祖细胞毒性。

Animal Model: Behavioral test (tail suspension and forced-swimming test) established in male ICR mice (18-22 g)
Dosage: 25, 50 and 100 mg/kg
Administration: Intragastric administration (i.g.), once daily, for 13 and 14 days
Result: Obviously decreased the immobility time in tail suspension test (TST) and forced swimming test (FST).
Animal Model: CUMS model established in in 8-week-old male C57BL/6 SPF mice (20 g)
Dosage: 50 mg/kg
Administration: Intragastric administration (i.g.), once daily, for 4 weeks
Result: Improved depressive in sucrose preference test (SPT), open field test (OFT), FTS and TST and anxiety-like behaviors in elevated plus-maze test (EPM).
Restored the reduction of intestinal microvilli and alleviated mitochondrial swelling.
Lowered the levels of IL-6, IL-1β, and TNF-α.
Restructured the gut microbiome, and microbial metabolism.
Animal Model: Xylene-induced hematotoxicity model established in male C57BL/6 SPF mice (8 weeks old, 20 g)
Dosage: 50 mg/kg
Administration: Intragastric administration (i.g.), once daily, for 25 days
Result: Significantly reversed the White blood cell count (WBC) reduction induced by xylene.
Restored the proportion of bone marrow LSK cells to the normal level.
Reduced the level of ROS in mitochondria and restored the mitochondrial membrane potential inhibited by xylene.
Acted directly on the Mgst2 target site (KD = 8.0861 kcal/mol).
性状 固体
颜色 White to off-white

化学信息

分子量 356.37
分子式 C20H20O6
CAS No. 63644-62-2
别名 阿魏酸松柏酯

储存&溶解度

体内实验配方
10% DMSO+90% Saline: 10 mg/mL (28.06 mM), Solution.
10% DMSO+90% Corn Oil: 2 mg/mL (5.61 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
储存方式

4°C, protect from light

*In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 100 mg/mL (280.61 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM2.8061 mL14.0304 mL28.0607 mL70.1518 mL
5 mM0.5612 mL2.8061 mL5.6121 mL14.0304 mL
10 mM0.2806 mL1.4030 mL2.8061 mL7.0152 mL
15 mM0.1871 mL0.9354 mL1.8707 mL4.6768 mL
20 mM0.1403 mL0.7015 mL1.4030 mL3.5076 mL
25 mM0.1122 mL0.5612 mL1.1224 mL2.8061 mL
30 mM0.0935 mL0.4677 mL0.9354 mL2.3384 mL
40 mM0.0702 mL0.3508 mL0.7015 mL1.7538 mL
50 mM0.0561 mL0.2806 mL0.5612 mL1.4030 mL
60 mM0.0468 mL0.2338 mL0.4677 mL1.1692 mL
80 mM0.0351 mL0.1754 mL0.3508 mL0.8769 mL
100 mM0.0281 mL0.1403 mL0.2806 mL0.7015 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

阿魏酸松柏酯 相关分类

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础